Head-to-head · WeighScore
bmiMD vs Idgie Health
By GLP-1 ScorecardUpdated
Score comparison
bmiMD has the higher recorded score — 79.2/100 to 75.4/100.
bmiMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | bmiMD | Idgie Health |
|---|---|---|
| WeighScore | 79.2/100 | 75.4/100 |
| Grade | C+ | C |
| Site position | #29 | #57 |
| Semaglutide | $159/mo month-to-month ($119/mo equivalent with $1,428 prepaid for 12 months) | $149/mo month-to-month ($114 only on a 6-month prepay) |
| Tirzepatide | $249/mo month-to-month ($179/mo equivalent with $2,148 prepaid for 12 months) | $229/mo month-to-month ($171 only on a 6-month prepay) |
| Coverage | All 50 states | A state-availability page is published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #29 · C+
Strengths
- Advertises the same price across prescribed doses for each selected injection plan
- Publishes compounded semaglutide and tirzepatide injection plans
- Every rung of both ladders is published with the total charge beside each per-month figure
- All 50 states
What to consider
- The pricing block opens on the 3-Month tab, so the figure a reader meets first is a commitment rate rather than a month
- The annual $119 and $179 monthly equivalents require $1,428 or $2,148 paid upfront for 12 months
- A struck-through $228.60 and $349.20 sit above the ladders under a standing LIMITED TIME label, with no published basis
- Neither the compounding pharmacy nor the prescribing group is named on the product pages
Site position #57 · C
Strengths
- Every rung carries the figure billed today — $387 at three months, $687 at six on semaglutide — not just a per-month number
- States the pharmacy class plainly: prescriptions ship from a licensed U.S. 503A pharmacy
- Names its operating entity, Feel Better Health Group, LLC, in the page footer rather than only in the Terms
- The plan covers the provider evaluation, all injection supplies, dose titration, unlimited provider messaging and free shipping
- An oral semaglutide and two microdose lines sit beside the injection
What to consider
- Both headlines are the six-month prepay: "From $114" against $149, and "From $171" against $229
- The Terms describe a recurring Membership Fee and exclude the online visit and labs from it, while the pricing page never uses the word and promises no hidden fees
- The same Terms name an Idgie Health Pharmacy Network and a Bask Pharmacy Network without dividing the work between them
- The semaglutide card says "all doses"; the tirzepatide card does not
Featured provider
bmiMD
bmiMD scores 79.2/100 (C+). bmiMD publishes monthly and prepaid injection plans with advertised pricing that stays the same across prescribed doses; its lowest monthly equivalents require a year upfront.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.